论文部分内容阅读
目的分析和研究丙种球蛋白静脉滴注用于辅助治疗小儿重症肺炎的临床效果。方法200例1~3个月小儿重症肺炎患儿,应用随机分组法分为试验组与对照组,各100例。对照组行肺炎综合对症治疗;试验组在肺炎综合对症治疗的同时静脉滴注丙种球蛋白。比较两组患儿治疗后的疗效、退热时间、咳嗽缓解时间、胸部阴影吸收时间、湿啰音消失时间、气促缓解时间及住院时间。结果试验组治疗总效率为90.00%,明显优于对照组的76.00%,差异有统计学意义(P<0.05)。试验组退热时间、咳嗽缓解时间、湿啰音消失时间、气促缓解时间均比对照组短,差异均有统计学意义(P<0.05)。试验组胸部阴影吸收时间、住院时间均比对照组短,差异均有统计学意义(P<0.05)。结论丙种球蛋白静脉滴注用于辅助治疗小儿重症肺炎的临床效果确切,可促进患儿发热、气促、咳嗽、湿啰音等症状快速好转,促进胸部阴影吸收,缩短住院时间,值得临床推广。
Objective To analyze and study the clinical effect of intravenous infusion of gamma globulin in adjuvant treatment of pediatric severe pneumonia. Methods A total of 200 infants with severe pneumonia aged 1 to 3 months were divided into experimental group and control group by randomization, each with 100 cases. The control group was treated with pneumonia comprehensive symptomatic treatment; the experimental group was given intravenous gamma globulin simultaneously with the symptomatic treatment of pneumonia. The curative effect, antipyretic time, cough relief time, chest shadow absorption time, wet rales disappearance time, shortness of breath relief time and hospital stay were compared between the two groups. Results The total effective rate of the experimental group was 90.00%, which was significantly better than that of the control group (76.00%), the difference was statistically significant (P <0.05). The test group antipyretic time, cough relief time, wet rales disappear time, shortness of breath relief time shorter than the control group, the difference was statistically significant (P <0.05). The chest shadow absorption time and hospital stay in the test group were shorter than those in the control group, with significant differences (P <0.05). Conclusion Intravenous infusion of gamma globulin is an effective adjuvant therapy for children with severe pneumonia. It can promote the rapid improvement of fever, shortness of breath, cough, wet rales and other symptoms in children, promote chest shadow absorption and shorten the length of hospital stay, which is worthy of clinical promotion .